lobbying_activities: 3375906

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id filing_uuid filing_type registrant_name registrant_id client_name filing_year filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
3375906 6f512d5e-4887-4bc2-be64-0b301598573f Q2 HORIZON GOVERNMENT AFFAIRS 315592 CENCORA FKA AMERISOURCEBERGEN CORPORATION 2025 second_quarter HCR Medicare Part B Issues; Drug pricing and access, including Inflation Reduction Act; Drug shortage issues; Medicare physician reimbursement issues; HR 405-EMSSA; Act; Seniors' Access to Critical Medications Act (H.R. 2484); HR1, the One Big Beautiful Bill Act; HHS - drug pricing issues, implementation of Inflation Reduction Act. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE 50000   0 0 2025-07-01T18:31:52-04:00